Samsung Medison acquires French AI startup Sonio
Samsung Medison, a Korean diagnostic ultrasound system maker under Samsung Electronics, signed a stock transfer agreement on Tuesday to acquire Sonio, a French AI development startup that offers diagnostic reporting technology for obstetrics and gynecology ultrasound.
The company explained that Samsung Medison plans to secure excellent AI development talent in Europe and introduce more improved AI capabilities by adding Sonio's AI diagnostic assistant and reporting technology to its medical AI solutions.
It also expects the technology collaboration with Sonio to dramatically reduce the time doctors spend diagnosing and improve the quality of diagnosis.
Founded in 2020, Sonio has developed various IT solutions and AI diagnostic aids that help medical staff easily check and manage patients' diagnosis history and history, centering on diagnostic software for obstetrics and gynecology ultrasound.
“Detect,” one of the functions developed by Sonio, is an AI diagnostic aid for obstetrics and gynecology that automatically recognizes diagnostic cross-sections for measuring fetal status and evaluates the quality and appropriateness of the screen. It won the marketing authorization from the U.S. Food and Drug Administration (FDA) in August 2023.
The French company also launched a new version with improved performance and succeeded in obtaining additional sales approval on April 26. The product proved its competitiveness by signing a large-scale supply contract in the United States.
Sonio's AI diagnostic reporting system quantifies and organizes the results of ultrasound scans. It is built on a cloud-based system, which reduces customers' initial investment costs compared to competitors and is easy to maintain.
"We are pleased to join forces with Sonio, a world-class obstetrics and gynecology solution," Samsung Medison CEO Kim Yong-kwan said. "With Sonio's superior ultrasound reporting and AI technology, we will work together to improve the quality of life for pregnant women around the world through medical advancements."